I am a researcher in the Translational Research Immunology Group (TRIG) at the University of Oxford, focusing on developing novel therapies to establish transplant tolerance. My work includes exploring interleukin-2-based compounds, modulation of iron availability, and adoptive Treg transfers. I completed my PhD at Université Paris Sorbonne, where I studied how human endothelial cells modulate immune responses and the impact of transplant-associated microenvironmental factors. Additionally, I am a member of the Basic Science Committee of the Transplantation Society (TTS).

My current research program centers on chronic tolerance and local injury in liver disease. I aim to uncover both common and disease-specific processes of intratissue inflammation and tolerance through multi-omic analysis of human liver samples. This research provides insights into cellular resistance to the hepatitis B virus (HBV), transplant pathology, and cancer development.